Atropine for the Treatment of Childhood Myopia

Published:September 21, 2006DOI:https://doi.org/10.1016/j.ophtha.2006.05.062

      Purpose

      To evaluate the efficacy and safety of topical atropine, a nonselective muscarinic antagonist, in slowing the progression of myopia and ocular axial elongation in Asian children.

      Design

      Parallel-group, placebo-controlled, randomized, double-masked study.

      Participants

      Four hundred children aged 6 to 12 years with refractive error of spherical equivalent −1.00 to −6.00 diopters (D) and astigmatism of −1.50 D or less.

      Intervention

      Participants were assigned with equal probability to receive either 1% atropine or vehicle eye drops once nightly for 2 years. Only 1 eye of each subject was chosen through randomization for treatment.

      Main Outcome Measures

      The main efficacy outcome measures were change in spherical equivalent refraction as measured by cycloplegic autorefraction and change in ocular axial length as measured by ultrasonography. The primary safety outcome measure was the occurrence of adverse events.

      Results

      Three hundred forty-six (86.5%) children completed the 2-year study. After 2 years, the mean progression of myopia and of axial elongation in the placebo-treated control eyes was −1.20±0.69 D and 0.38±0.38 mm, respectively. In the atropine-treated eyes, myopia progression was only −0.28±0.92 D, whereas the axial length remained essentially unchanged compared with baseline (−0.02±0.35 mm). The differences in myopia progression and axial elongation between the 2 groups were −0.92 D (95% confidence interval, −1.10 to −0.77 D; P<0.001) and 0.40 mm (95% confidence interval, 0.35–0.45 mm; P<0.001), respectively. No serious adverse events related to atropine were reported.

      Conclusions

      Topical atropine was well tolerated and effective in slowing the progression of low and moderate myopia and ocular axial elongation in Asian children.
      To read this article in full you will need to make a payment
      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lin L.L.
        • Shih Y.F.
        • Tsai C.B.
        • et al.
        Epidemiologic study of ocular refraction among schoolchildren in Taiwan in 1995.
        Optom Vis Sci. 1999; 76: 275-281
        • Wu H.M.
        • Seet B.
        • Yap E.P.
        • et al.
        Does education explain ethnic differences in myopia prevalence?.
        Optom Vis Sci. 2001; 78: 234-239
        • Wang Q.
        • Klein B.
        • Klein R.
        • Moss S.
        Refractive status in the Beaver Dam Eye Study.
        Invest Ophthalmol Vis Sci. 1994; 35: 4344-4347
        • Saw S.M.
        • Katz J.
        • Schein O.D.
        • et al.
        Epidemiology of myopia.
        Epidemiol Rev. 1996; 18: 175-187
        • Katz J.
        • Tielsch J.M.
        • Sommer A.
        Prevalence and risk factors for refractive errors in an adult inner city population.
        Invest Ophthalmol Vis Sci. 1997; 38: 334-340
        • Mutti D.O.
        • Bullimore M.A.
        Myopia: an epidemic of possibilities?.
        Optom Vis Sci. 1999; 76: 257-258
        • Framingham Offspring Eye Study Group
        Familial aggregation and prevalence of myopia in the Framingham Offspring Eye Study.
        Arch Ophthalmol. 1996; 114: 326-332
        • Goldschmidt E.
        Ocular morbidity in myopia.
        Acta Ophthalmol Suppl. 1988; 185: 86-87
        • Eye Disease Case-Control Study Group
        Risk factors for idiopathic rhegmatogenous retinal detachment.
        Am J Epidemiol. 1993; 137: 749-757
        • Mitchell P.
        • Hourihan F.
        • Sandbach J.
        • Wang J.J.
        The relationship between glaucoma and myopia: the Blue Mountains Eye Study.
        Ophthalmology. 1999; 106: 2010-2015
        • Gwiazda J.
        • Hyman L.
        • Hussein M.
        • et al.
        A randomized clinical trial of progressive addition lenses versus single vision lenses on the progression of myopia in children.
        Invest Ophthalmol Vis Sci. 2003; 44: 1492-1500
        • Edwards M.H.
        • Li R.W.
        • Lam C.S.
        • et al.
        The Hong Kong Progressive Lens Myopia Control Study: study design and main findings.
        Invest Ophthalmol Vis Sci. 2002; 43: 2852-2858
        • Katz J.
        • Schein O.D.
        • Levy B.
        • et al.
        A randomized trial of rigid gas permeable contact lenses to reduce progression of children’s myopia.
        Am J Ophthalmol. 2003; 136: 82-90
        • Yen M.Y.
        • Liu J.H.
        • Kao S.C.
        • Shiao C.H.
        Comparison of the effect of atropine and cyclopentolate on myopia.
        Ann Ophthalmol. 1989; 21 (187): 180-182
        • Shih Y.F.
        • Chen C.H.
        • Chou A.C.
        • et al.
        Effects of different concentrations of atropine on controlling myopia in myopic children.
        J Ocul Pharmacol Ther. 1999; 15: 85-90
        • Shih Y.F.
        • Hsiao C.K.
        • Chen C.J.
        • et al.
        An intervention trial on efficacy of atropine and multi-focal glasses in controlling myopic progression.
        Acta Ophthalmol Scand. 2001; 79: 233-236
        • Saw S.M.
        • Chan E.S.
        • Koh A.
        • Tan D.
        Interventions to retard myopia progression in children: an evidence-based update.
        Ophthalmology. 2002; 109 (discussion 422–4): 415-421
        • Machin D.
        • Campbell M.J.
        • Fayers P.M.
        • Pinol A.P.
        Sample Size Tables for Clinical Studies. 2nd ed. Blackwell Science, Oxford, United Kingdom1997: 18-69
        • Thibos L.N.
        • Wheeler W.
        • Horner D.
        Power vectors: an application of Fourier analysis to the description and statistical analysis of refractive error.
        Optom Vis Sci. 1997; 74: 367-375
        • Luu C.D.
        • Lau A.M.
        • Koh A.H.
        • Tan D.
        Multifocal electroretinogram in children on atropine treatment for myopia.
        Br J Ophthalmol. 2005; 89: 151-153
        • Rosenfield M.
        Accommodation and myopia.
        in: Rosenfield M. Gilmartin B. Myopia and Nearwork. 12th ed. Butterworth-Heinemann, Oxford, United Kingdom1998: 91-116
        • McBrien N.A.
        • Moghaddam H.O.
        • Reeder A.P.
        Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism.
        Invest Ophthalmol Vis Sci. 1993; 34: 205-215
        • Curtin B.J.
        The Myopias: Basic Science and Clinical Management. Harper and Row, Philadelphia1985: 222
        • Pediatric Eye Disease Investigator Group
        A randomized trial of atropine vs patching for treatment of moderate amblyopia in children.
        Arch Ophthalmol. 2002; 120: 268-278